Skip to content

Randomized trial of preventing complete avoidance in challenge-proven severe egg-allergic infants

Randomized trial of preventing complete avoidance in challenge-proven severe egg-allergic infants - Randomized trial of preventing complete avoidance in challenge-proven severe egg-allergic infants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027332
Enrollment
54
Registered
2017-05-16
Start date
2017-05-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hen&#39

Interventions

Daily intake of heated hen&#39
s egg powder for 6 months. The dose of intake for the initial 1 month is 0.2g of heated hen&#39
egg powder (50mg of egg protein). After 1 month, the intake amount is gradually increased towards the target dose of 1g of heated hen&#39
s egg powder (250mg of egg protein). Daily intake of placebo powder for 6 months. The dose of intake for the initial 1 month is 0.2g of placebo powder. After 1 month, the intake amount is gradually

Sponsors

National Hospital Organization Sagamihara National Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Positive oral food challenge to 1/32 of heated hen's egg (250mg of egg protein) within 3 months of initiation of the trial. Capable of consuming 1/160 of heated hen's egg (50mg of egg protein) without allergic symptoms.

Exclusion criteria

Exclusion criteria: Severe allergic symptoms or symptoms requiring the use of adrenaline during the oral food challenge to 1/32 of heated hen's egg (250mg of egg protein). Regular intake of hen's egg before initiation of trial. Severe (uncontrolled) atopic dermatitis before intiation of trial. Two or more hospitalizations due to wheezing episodes in the previous 6 months before initiation of trial

Design outcomes

Primary

MeasureTime frame
Proportion of patients desensitized to 1/8 of heated hen's egg after 6 months, confirmed with a double-blind, placebo-controlled food challenge (DBPCFC)

Secondary

MeasureTime frame
Frequency and severity of adverse events at home during the trial. Changes in egg white and ovomucoid specific IgE, IgG, IgG4 measured before trial and after 6 and 12 months of the trial. Changes in skin prick test results tested before trial and after 6 and 12 months of the trial. Sustained unresponsiveness to 1/2 of heated hen's egg within 1.5 years of initiation of the trial.

Countries

Japan

Contacts

Public ContactMakoto Nishino

National Hospital Organization Sagamihara National Hospital Department of Pediatrics

precastudy@gmail.com042-742-8311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026